On March 29, the FDA approved the first nonprescription, 'over-the-counter' (OTC) naloxone nasal spray, Narcan. Naloxone--a medicine that can reverse an opioid-related overdose--has been shown to be a critical tool to prevent fatal overdoses, connect more people to treatment for substance use disorder, and save lives.
FDA approves Narcan 4mg nasal spray for OTC use
Apr 4, 2023 8:00:00 AM / by Practice Support Team posted in overdose, opioid use disorder
Forsyth Regional Community Crisis Resource Guide
May 25, 2022 7:43:00 AM / by Practice Support Team posted in behavioral health, care management, harm reduction, overdose, opioid use disorder
The Forsyth Regional Opioid & Substance Use Team (FROST) is made up of representatives from over 80 different community agencies in addition to community members with lived experiences.
